---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-177636"
form_type: "8-K"
ticker: "ABOS"
cik: "0001576885"
company_name: "Acumen Pharmaceuticals, Inc."
filed_at: "2022-06-21T23:59:59+00:00"
generated_at: "2026-06-25T00:24:02.387832+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Acumen shareholders elect all director nominees and ratify E&Y as auditor at annual meeting

## Summary
- All three Class I director nominees elected: Kimberlee C. Drapkin, Jeffrey Ives (Ph.D.), Sean Stalfort; broker non-votes of 5,658,008.
- Ratification of Ernst & Young as independent auditor received 34,702,393.73 votes for, 761.18 against, 165 abstentions.
- Approximately 85.69% of outstanding shares (34,703,319.92 of 40,496,512) were present or represented at the meeting.

## SEC filing metadata
- accession: 0001193125-22-177636
- form_type: 8-K
- ticker: ABOS
- cik: 0001576885
- company_name: Acumen Pharmaceuticals, Inc.
- filed_at: 2022-06-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1576885/000119312522177636/0001193125-22-177636-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1576885/000119312522177636/d371573d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-177636
- JSON: https://secwatch.observer/filing/0001193125-22-177636.json
- Plain text: https://secwatch.observer/filing/0001193125-22-177636.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.